Ferring Pharmaceuticals News and Activities

Ferring Pharmaceuticals has a direct presence in 3 countries.

View the org chart displaying its 42 main executives

Most searched biographies at Ferring Pharmaceuticals

• Jean-Frédéric Paulsen, Executive Chairman of the Board and Chief...
• Lars Rebien Sorensen, Vice Chairman of the Board
• Frederik Paulsen, Director

Popular executive movements at Ferring Pharmaceuticals

• Krishnakumar N has joined the company as Director, External Manufacturing Network  (posted on April 13 2026).
• Armin Metzger, Executive Vice President and Chief Technical Operations Officer, will leave the company on Apr. 1, 2026  (posted on March 27 2026).
• Luzi von Bidder, Director, has left the company  (posted on March 27 2026).

Click here to view some more movements at Ferring Pharmaceuticals

Create your alert
to follow the executive moves at Ferring Pharmaceuticals.

Ferring Pharmaceuticals has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Ferring Pharmaceuticals

• Press releases - Ferring Pharmaceuticals
• Press releases - Ferring Pharmaceuticals
• PRESS RELEASE 2020 Archives - Ferring Pharmaceuticals
• Press releases - Ferring Pharmaceuticals
• PRESS RELEASE 2020 Archives - Ferring Pharmaceuticals
• Press releases - Ferring Corporate
• Rebiotix, a Ferring Company, Completes Enrollment for First-Ever, Pivotal Phase 3 Clinical Trial of Microbiota-based RBX2660 - Ferring Corporate
• Ferring’s Propess® is the first pharmacological treatment for cervical ripening to be approved in Japan for over 20 years - Ferring Corporate
• FerGene Appoints David Meek Chief Executive Officer - Ferring Corporate
• FerGene announces pivotal Phase 3 study of nadofaragene firadenovec met its primary endpoint with more than half of patients with high-grade non-muscle invasive bladder cancer (CIS ± Ta/T1) achieving a complete response at three months - Ferring Corporate
• View more press releases Close

Social media about Ferring Pharmaceuticals

• Ferring Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Ferring Pharmaceuticals on LinkedIn, X (Twitter) & YouTube